Smith Karen L. - Insider Non-Derivative Transactions at SANGAMO THERAPEUTICS, INC (SGMO) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jun 4, 2024, Smith Karen L.'s relationship to SANGAMO THERAPEUTICS, INC (SGMO) is Director, and currently has 77,100 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other SGMO insiders.
Data Source: SEC.
Smith Karen L. - Insider Non-Derivative Transactions of SGMO Common Stock
Smith Karen L. - Insider Non-Derivative Transactions at SGMO
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jun 5, 2024 | Acquisition -- (Common Stock) | 25000 | 0 | 77100 |
| Jun 2, 2023 | Acquisition -- (Common Stock) | 13900 | 0 | 52100 |